Government sets possible R&D spending criteria

The Ministry of Health and Welfare has unveiled an ambitious vision to foster global pharmaceutical firms by providing a total of 146 billion won in subsidies to “innovative pharmaceutical firms” that post more than 100 billion won in sales and invest at least 5 percent of their revenue in research and development or those that record less than 100 billion won in sales but spend more than 7 per...